GlassScriptPhysician profile
Brian Rowan
NPI 1710370903
$3,874.48
in general payments reported to CMS, 2019-2025
9 companies · $861 in 2025
The $861 reported for 2025 was more than what 80% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.69 · 2021: $416 · 2022: $538 · 2023: $551 · 2024: $1,435 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,459 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $231 · Education: $100 · Gift: $56.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,458.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $231.35 |
| Education | $100.00 |
| Gift | $56.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,039.00 | 2021-2025 | |
| Kls-Martin L.P. | $1,111.73 | 2021-2025 | |
| Stryker Corporation | $432.19 | 2021-2025 | Na, Vsp System, Vsp Cranial |
| Nobel Biocare USA | $84.19 | 2023 | Nobelactive |
| Henry Schein, INC. | $39.10 | 2025 | |
| Abbvie INC. | $29.26 | 2023 | |
| Depuy Synthes Sales INC. | $29.05 | 2021 | |
| Dentsply Sirona INC | $21.28 | 2023 | Primescan Connect |
| Pacira Pharmaceuticals Incorporated | $14.99 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.